Mitochondrial dysfunction and redox imbalance as a diagnostic marker of Free radical diseases
Kim KI, Jung KE, Shin YB, Kim CD, Yoon TJ
Direct human clinical trial evidence
9,394,338 Applications Treatment for Alzheimers and other neurodegenerative diseases Key Benefits & Differentiators Increased stability: Resistance to -glutamyl transpeptidase (-GT) breakdown leads to extended antioxidant activity Replicates endogenous GSH activity: Crosses the blood-brain barrier and mimics key glutathione (GSH) functions Technology Overview Oxidative stress and plaque formation from glycation are key features of numerous neurodegenerative diseases, including Alzheimers disease
Parkinson's Disease IV Treatments Dr
Request third-party HPLC chromatograms showing purity greater than 98%, mass spectrometry reports confirming correct molecular weight (1419.55 Da for BPC-157, for example), and certificates of analysis including endotoxin testing results